parallax background

Pushing boundaries in the field of Assisted

Reproductive Technology

About

With over 48.5 million couples worldwide unable to have children after 5 years of trying, The World Health Organization (WHO) ranks infertility as the third most serious health condition in the world, after cancer and heart disease. With an immediate focus on advanced technology to prevent genetic disease, Darwin Life is uniquely positioned to revolutionize the scope of reproductive technology, offering comprehensive treatments, products, and services to address reproductive aging, geriatric health, and longevity.

Learn More
parallax background

Technology

HER IVF is a revolutionary technology designed to reverse the effects of age on human oocytes and repair certain cellular defects. Using an advanced egg environment-exchange protocol called Spindle Nuclear Transfer, Darwin Life has surpassed both the “3-Parent IVF” technique in the United Kingdom and “Cell Augmentation” in Canada, to create the world’s first, healthy, live-birth, baby boy from Spindle Nuclear Transfer.


Learn More

Leadership/Founders

John Zhang, MD, PhD, MSc, Chief Medical Officer, CEO

Doctor John Zhang, Founder/CEO of Darwin Life is a practicing Reproductive Endocrinologist and Infertility specialist. He is celebrated as a pioneer in the area of Minimal Stimulation In Vitro Fertilization (Mini-IVF™), Natural IVF, and American Egg Freezing using Vitrification.

Learn More

Zhuo Lu, PhD, Senior Research Officer

Doctor Zhuo Lu is widely recognized as a professional contributor to over a dozen landmark studies that have been published recently and supports Darwin Life through World Class embryonic research and development including Low Stimulation IVF.


Learn More

Hui Liu, MD, PhD, MSc, Chief Scientific Advisor

Doctor Hui Liu is an internationally recognized Reproductive Scientist and Embryologist. He serves as the Chief Scientific Advisor for Darwin life, contributing significantly to the development of Pronuclear Transfer techniques including GV Transfer, MII Spindle transfer, and PN transfer.

Learn More

Alejandro Chávez, Medical Director & Founder of NHFC Mexico

Pioneer in vitro fertilization treatments with minimal stimulation and leader in the global transformation of conventional IVF treatments. Member of several international medical societies. He has published research on endometriosis, andrology and assisted reproduction.

Learn More
parallax background

NEWS/RESEARCH

Research: Pregnancy derived from human zygote
Zhang, J. (2016). Pregnancy derived from human zygote pronuclear transfer in a patient who had arrested embryos after IVF. ReprodBiomed Online. Aug 1.
Nuclear Transfer Publication August 2016

Learn More